Arrowstreet Capital’s Enfusion, Inc. ENFN Stock Holding History

Arrowstreet Capital’s Portfolio ENFN Stock Details ENFN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,326,923	Closed	-$14.8M	–	2126
2025 Q1	$14.8M	Buy	1,326,923 +1,098,025	+480%	+$12.1M	0.01%	692
2024 Q4	$2.36M	Buy	+228,898	New	+$2.21M	﹤0.01%	1232
2023 Q3	–	Sell	-27,763	Closed	-$312K	–	1457
2023 Q2	$312K	Sell	27,763 -32,368	-54%	-$287K	﹤0.01%	1116
2023 Q1	$631K	Buy	+60,131	New	+$663K	﹤0.01%	1143

Other funds holding ENFN

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Arrowstreet Capital's ENFN Position: Q2 2025 in Review

Arrowstreet Capital sold out of Enfusion, Inc. (ENFN) in Q2 2025, closing a stake of 1,326,923 shares — an estimated $14.8M sold.

Arrowstreet Capital first reported a position in ENFN in Q1 2023 and held it in 4 quarters. The position peaked at $14.8M in Q1 2025. 2 funds tracked by Wall St. Rank hold ENFN as of Q2 2025.

Arrowstreet Capital reported no remaining Enfusion, Inc. position as of Q2 2025 after selling out during the quarter.
Arrowstreet Capital sold 1,326,923 Enfusion, Inc. shares in Q2 2025, an estimated $14.8M.
Arrowstreet Capital first reported a position in Enfusion, Inc. in Q1 2023 and held it in 4 quarters.
Arrowstreet Capital's Enfusion, Inc. position peaked at $14.8M in Q1 2025.
2 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2025.

Based on Arrowstreet Capital's 13F filing for Q2 2025, filed 13 Aug 2025.